Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Developmental refractoriness of MLL-rearranged human B-cell acute leukemias to reprogramming into pluripotency

  • Muñoz, Alvaro
  • Romero Moya, Damià
  • Prieto, Cristina
  • Ramos-Mejía, Verónica
  • Agraz-Doblas, Antonio
  • Varela, Ignacio
  • Buschbeck, Marcus
  • Palau de Miguel, Anna
  • Carvajal-Vergara, Xonia
  • Giorgetti, Alessandra
  • Ford, Anthony
  • Lako, Majlinda
  • Granada, Isabel
  • Ruiz-Xivillé, Neus
  • Rodríguez-Perales, Sandra
  • Torres-Ruíz, Raul
  • Stam, Ronald W.
  • Fuster, Jose Luis
  • Fraga, Mario F.
  • Nakanishi, Mahito
  • Cazzaniga, Gianni
  • Bardini, Michela
  • Cobo, Isabel
  • Bayón, Gustavo F.
  • Fernández, Agustín F.
  • Bueno, Clara
  • Menéndez Buján, Pablo
Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling. They are routinely generated from healthy donors and patients from multiple cell types at different developmental stages. However, reprogramming leukemias is an extremely inefficient process. Few studies generated iPSCs from primary chronic myeloid leukemias, but iPSC generation from acute myeloid or lymphoid leukemias (ALL) has not been achieved. We attempted to generate iPSCs from different subtypes of B-ALL to address the developmental impact of leukemic fusion genes. OKSM(L)-expressing mono/polycistronic-, retroviral/lentiviral/episomal-, and Sendai virus vector-based reprogramming strategies failed to render iPSCs in vitro and in vivo. Addition of transcriptomic-epigenetic reprogramming 'boosters' also failed to generate iPSCs from B cell blasts and B-ALL lines, and when iPSCs emerged they lacked leukemic fusion genes, demonstrating non-leukemic myeloid origin. Conversely, MLL-AF4-overexpressing hematopoietic stem cells/B progenitors were successfully reprogrammed, indicating that B cell origin and leukemic fusion gene were not reprogramming barriers. Global transcriptome/DNA methylome profiling suggested a developmental/differentiation refractoriness of MLL-rearranged B-ALL to reprogramming into pluripotency.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Estudios de expresión génica en el modelo murino del Síndrome de Allan-Herndon-Dudley

  • Morte, Beatriz
  • Gil-Ibáñez, Pilar
  • Bernal, Juan
Resumen del trabajo presentado a la VIII Reunión Científica Anual del Centro de Investigación Biomédica En Red de Enfermedades Raras, celebrada en San Lorenzo del Escorial (Madrid) los días 12 y 13 de marzo de 2015., El síndrome de Allan-Herndon-Dudley se debe a mutaciones del gen MCT8 (SLC16A2), que codifica un transportador de hormonas tiroideas (HT). Es una grave alteración neurológica con profundo retraso mental y psicomotor ligado al cromosoma X y se postula se deba a un defecto de señalización por HT en el cerebro en desarrollo. Estudios en ratones knockout de Mct8 han puesto de manifiesto la relevancia de la expresión de MCT8 en la barrera hematoencefálica donde radica la restricción al paso de la T3 al cerebro pero no así de la T4, por transportadores alternativos, como Oatp1c1, que permite mantener el cerebro de estos animales sin alteraciones morfológicas. Estos mecanismos podrían estar ausentes en el humano y causar el grave deterioro. La doble inactivación Mct8/Oatp1c1 se ha propuesto como modelo experimental de la enfermedad. Para cuantificar la acción de la T3 empleamos la información del conjunto de genes regulados por HT y analizamos su sensibilidad a la ausencia de Mct8, Oatp1c1, y ambos comparando con la deprivación de HT (hipotiroidismo). Resultados preliminares de nuestro laboratorio indican que en la corteza cerebral, genes diana de HT cuya expresión no se altera en la ausencia de Mct8 presentan niveles similares a los producidos por el hipotiroidismo tras la doble inactivación Mct8/Oatp1c1. Actualmente estamos ampliando estos estudios mediante el análisis del transcriptoma (RNASeq) para evaluar la repercusión de la ausencia de los transportadores en la señalización por HT en diferentes regiones cerebrales., CIBER a través de E-Rare2 (ERA-Net for Research on Rare Disseases), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Editorial: Role of stem cells in skeletal muscle development, regeneration, repair, aging and disease

  • Muñoz-Cánoves, Pura
  • Carvajal, Jaime J.
  • López de Munain, Adolfo
  • Izeta, Ander
Skeletal muscle is a highly dynamic and plastic tissue, able to modify its intrinsic size or strength following electric impulse, mechanical loading, or diet. Several muscular dystrophic disorders have been characterized but the development of therapies, although promising, is still at an early phase. Muscle dysfunction is not restricted to dystrophic patients; during aging, there is a gradual loss of muscle function that results in a significant negative impact on the individual's health, increasing fall and lesion risks, loss of mobility and independence, and associated elevation of morbidity and mortality. This loss of muscle has an estimated prevalence between 5 and 13% among 60–70 year old individuals, increasing to 11–50% in those over the age of 80 (Morley, 2008). According to the WHO, the expected number of individuals over 65 years old by the year 2050 will be around 1.5 billion (WHO, 2015); by extrapolation, this suggests that over 150 million patients will suffer from muscle wasting disorders associated with aging., Work in our labs was supported by grants from Instituto de Salud Carlos III (ISCIII; PI13/02172 to AI and PI14/7436, CIBERNED and Fundación Isabel Gemio to ALM); from SAF2012-38547, SAF2015-67369-R, AFM, Marató-TV3, E-Rare/Eranet, MDA to PM; JC received support from the Spanish Ministry of Science (BFU2014-54194-P), the AFM and the European Commission (CIG-303904). AI was supported by the Programa I3SNS (CES09/015) from ISCIII and by Osakidetza-Servicio Vasco de Salud (Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Development refractoriness of MLL-rearranged human B cell acute leukemias to reprogramming into pluripotency

  • Muñoz-López, Alvaro
  • Prieto López, Cristina
  • Agraz-Doblas, Antonio
  • Varela, Ignacio
  • Menéndez, Pablo
et al., Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling. They are routinely generated from healthy donors and patients from multiple cell types at different developmental stages. However, reprogramming leukemias is an extremely inefficient process. Few studies generated iPSCs from primary chronic myeloid leukemias, but iPSC generation from acute myeloid or lymphoid leukemias (ALL) has not been achieved. We attempted to generate iPSCs from different subtypes of B-ALL to address the developmental impact of leukemic fusion genes. OKSM(L)-expressing mono/polycistronic-, retroviral/lentiviral/episomal-, and Sendai virus vector-based reprogramming strategies failed to render iPSCs in vitro and in vivo. Addition of transcriptomic-epigenetic reprogramming “boosters” also failed to generate iPSCs from B cell blasts and B-ALL lines, and when iPSCs emerged they lacked leukemic fusion genes, demonstrating non-leukemic myeloid origin. Conversely, MLL-AF4-overexpressing hematopoietic stem cells/B progenitors were successfully reprogrammed, indicating that B cell origin and leukemic fusion gene were not reprogramming barriers. Global transcriptome/DNA methylome profiling suggested a developmental/differentiation refractoriness of MLL-rearranged B-ALL to reprogramming into pluripotency., This work was supported by the European Research Council to P.M. (ERC-2014-CoG-646903), the ISCIII/FEDER (E-Rare-2 Call PI12/03112 to P.M. and PI14/01191 to C.B.), MINECO (SAF2013-43065 to P.M.), and the Spanish Association Against Cancer (AECC) to P.M. and C.B. C.B. is supported by a Miguel Servet II contract (CPII13/00011). D.R.M. and A.M.-L. are supported by PFIS (FI11/0511) and FPI (BES-2014-067844) scholarships, respectively. P.M. also acknowledges financial support from the Obra Social La Caixa, Fundaciò Josep Carreras and The Generalitat de Catalunya (SGR330). Open Access funded by European Research Council., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of gene expression by thyroid hormone in primary astrocytes: Factors influencing the genomic response

  • Morte, Beatriz
  • Gil-Ibáñez, Pilar
  • Bernal, Juan
Astrocytes mediate the action of thyroid hormone in the brain on other neural cells through the production of the active hormone triiodothyronine (T3) from its precursor thyroxine. T3 has also many effects on the astrocytes in vivo and in culture, but whether these actions are directly mediated by transcriptional regulation is not clear. In this work, we have analyzed the genomic response to T3 of cultured astrocytes isolated from the postnatal mouse cerebral cortex using RNA sequencing. Cultured astrocytes express relevant genes of thyroid hormone metabolism and action encoding type 2 deiodinase (Dio2), Mct8 transporter (Slc16a2), T3 receptors (Thra1 and Thrb), and nuclear corepressor (Ncor1) and coactivator (Ncoa1). T3 changed the expression of 668 genes (4.5% of expressed genes), of which 117 were responsive to T3 in the presence of cycloheximide. The Wnt and Notch pathways were downregulated at the posttranscriptional level. Comparison with the effect of T3 on astrocyte-enriched genes in mixed cerebrocortical cultures isolated from fetal cortex revealed that the response to T3 is influenced by the degree of astrocyte maturation and that, in agreement with its physiological effects, T3 promotes the transition between the fetal and adult patterns of gene expression., This work was supported by the Center for Biomedical Research on Rare Diseases under the framework of E-Rare-2, the ERA-Net for Research on Rare Diseases (project acronym THYRONERVE); Grant SAF2014-54919-R from the Plan Nacional de I+D+I of Ministry of Economy and Competitivity of Spain; and by the European Regional Funds., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Developmental refractoriness of MLL-rearranged human B-cell acute leukemias to reprogramming into pluripotency

  • Muñoz, Alvaro
  • Romero Moya, Damià
  • Prieto, Cristina
  • Ramos-Mejía, Verónica
  • Agraz-Doblas, Antonio
  • Varela, Ignacio
  • Buschbeck, Marcus
  • Palau de Miguel, Anna
  • Carvajal-Vergara, Xonia
  • Giorgetti, Alessandra
  • Ford, Anthony
  • Lako, Majlinda
  • Granada, Isabel
  • Ruiz-Xivillé, Neus
  • Rodríguez-Perales, Sandra
  • Torres-Ruíz, Raul
  • Stam, Ronald W.
  • Fuster, Jose Luis
  • Fraga, Mario F.
  • Nakanishi, Mahito
  • Cazzaniga, Gianni
  • Bardini, Michela
  • Cobo, Isabel
  • Bayón, Gustavo F.
  • Fernández, Agustín F.
  • Bueno, Clara
  • Menéndez Buján, Pablo
Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling. They are routinely generated from healthy donors and patients from multiple cell types at different developmental stages. However, reprogramming leukemias is an extremely inefficient process. Few studies generated iPSCs from primary chronic myeloid leukemias, but iPSC generation from acute myeloid or lymphoid leukemias (ALL) has not been achieved. We attempted to generate iPSCs from different subtypes of B-ALL to address the developmental impact of leukemic fusion genes. OKSM(L)-expressing mono/polycistronic-, retroviral/lentiviral/episomal-, and Sendai virus vector-based reprogramming strategies failed to render iPSCs in vitro and in vivo. Addition of transcriptomic-epigenetic reprogramming 'boosters' also failed to generate iPSCs from B cell blasts and B-ALL lines, and when iPSCs emerged they lacked leukemic fusion genes, demonstrating non-leukemic myeloid origin. Conversely, MLL-AF4-overexpressing hematopoietic stem cells/B progenitors were successfully reprogrammed, indicating that B cell origin and leukemic fusion gene were not reprogramming barriers. Global transcriptome/DNA methylome profiling suggested a developmental/differentiation refractoriness of MLL-rearranged B-ALL to reprogramming into pluripotency.